Evidence map›Paper›PMID 25875935›Full record

ArticlePloS one2015

Insulin reverses D-glucose-increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells.

Marcelo González, Susana Rojas, Pía Avila, Lissette Cabrera, Roberto Villalobos, Carlos Palma, Claudio Aguayo, Eduardo Peña, Victoria Gallardo, Enrique Guzmán-Gutiérrez and 6 more

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Microglia at the blood brain barrier in health and disease.Frontiers in cellular neuroscience · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Antioxidants (Basel, Switzerland) · 2020
    Article
  14. Article
  15. Development of an Organ-on-a-Chip-Device for Study of Placental Pathologies.International journal of molecular sciences · 2020
    Article
  16. Lowering oxidative stress in ghrelin cells stimulates ghrelin secretion.American journal of physiology. Endocrinology and metabolism · 2020
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marcelo GonzálezVascular Physiology Laboratory, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, P.O. Box 160-C, Concepción 4070386, Chile; Group of Research and Innovation in Vascular Health (GRIVAS-Health), PO-Box 114-D, Chillán 3800708, Chile.
Susana RojasVascular Physiology Laboratory, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, P.O. Box 160-C, Concepción 4070386, Chile.
Pía AvilaVascular Physiology Laboratory, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, P.O. Box 160-C, Concepción 4070386, Chile.
Lissette CabreraVascular Physiology Laboratory, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, P.O. Box 160-C, Concepción 4070386, Chile; Department of Morphophysiology, Faculty of Medicine, Universidad Diego Portales, Santiago 8370076, Chile.
Roberto VillalobosCellular and Molecular Physiology Laboratory (CMPL), Division of Obstetrics and Gynaecology, School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, P.O. Box 114-D, Santiago 8330024, Chile.
Carlos PalmaVascular Physiology Laboratory, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, P.O. Box 160-C, Concepción 4070386, Chile.
Claudio AguayoDepartment of Clinical Biochemistry and Immunology, Faculty of Pharmacy, Universidad de Concepción, P.O. Box 160-C, Concepción 4070386, Chile; Group of Research and Innovation in Vascular Health (GRIVAS-Health), PO-Box 114-D, Chillán 3800708, Chile.
Eduardo PeñaDepartment of Physiopathology, Faculty of Biological Sciences, Universidad de Concepción, P.O. Box 160-C, Concepción 4070386, Chile.
Victoria GallardoDepartment of Physiopathology, Faculty of Biological Sciences, Universidad de Concepción, P.O. Box 160-C, Concepción 4070386, Chile.
Enrique Guzmán-GutiérrezGroup of Research and Innovation in Vascular Health (GRIVAS-Health), PO-Box 114-D, Chillán 3800708, Chile; Faculty of Health Sciences, Universidad San Sebastián, Concepción 4080871, Chile.
Tamara SáezCellular and Molecular Physiology Laboratory (CMPL), Division of Obstetrics and Gynaecology, School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, P.O. Box 114-D, Santiago 8330024, Chile.
Rocío SalsosoCellular and Molecular Physiology Laboratory (CMPL), Division of Obstetrics and Gynaecology, School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, P.O. Box 114-D, Santiago 8330024, Chile.
Carlos SanhuezaCellular and Molecular Physiology Laboratory (CMPL), Division of Obstetrics and Gynaecology, School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, P.O. Box 114-D, Santiago 8330024, Chile.
Fabián PardoCellular and Molecular Physiology Laboratory (CMPL), Division of Obstetrics and Gynaecology, School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, P.O. Box 114-D, Santiago 8330024, Chile.
Andrea LeivaCellular and Molecular Physiology Laboratory (CMPL), Division of Obstetrics and Gynaecology, School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, P.O. Box 114-D, Santiago 8330024, Chile.
Luis SobreviaUniversity of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine and Biomedical Sciences, University of Queensland, Herston, QLD 4029, Queensland, Australia; Department of Physiology, Faculty of Pharmacy, Universidad de Sevilla, Seville E-41012, Spain; Cellular and Molecular Physiology Laboratory (CMPL), Division of Obstetrics and Gynaecology, School of Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, P.O. Box 114-D, Santiago 8330024, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular tone is controlled by the L-arginine/nitric oxide (NO) pathway, and NO bioavailability is strongly affected by hyperglycaemia-induced oxidative stress. Insulin leads to high expression and activity of human cationic amino acid transporter 1 (hCAT-1), NO synthesis and vasodilation; thus, a protective role of insulin on high D-glucose-alterations in endothelial function is likely. Vascular reactivity to U46619 (thromboxane A2 mimetic) and calcitonin gene related peptide (CGRP) was measured in KCl preconstricted human umbilical vein rings (wire myography) incubated in normal (5 mmol/L) or high (25 mmol/L) D-glucose. hCAT-1, endothelial NO synthase (eNOS), 42 and 44 kDa mitogen-activated protein kinases (p42/44mapk), protein kinase B/Akt (Akt) expression and activity were determined by western blotting and qRT-PCR, tetrahydrobiopterin (BH4) level was determined by HPLC, and L-arginine transport (0-1000 μmol/L) was measured in response to 5-25 mmol/L D-glucose (0-36 hours) in passage 2 human umbilical vein endothelial cells (HUVECs). Assays were in the absence or presence of insulin and/or apocynin (nicotinamide adenine dinucleotide phosphate-oxidase [NADPH oxidase] inhibitor), tempol or Mn(III)TMPyP (SOD mimetics). High D-glucose increased hCAT-1 expression and activity, which was biphasic (peaks: 6 and 24 hours of incubation). High D-glucose-increased maximal transport velocity was blocked by insulin and correlated with lower hCAT-1 expression and SLC7A1 gene promoter activity. High D-glucose-increased transport parallels higher reactive oxygen species (ROS) and superoxide anion (O2•-) generation, and increased U46619-contraction and reduced CGRP-dilation of vein rings. Insulin and apocynin attenuate ROS and O2•- generation, and restored vascular reactivity to U46619 and CGRP. Insulin, but not apocynin or tempol reversed high D-glucose-increased NO synthesis; however, tempol and Mn(III)TMPyP reversed the high D-glucose-reduced BH4 level. Insulin and tempol blocked the high D-glucose-increased p42/44mapk phosphorylation. Vascular dysfunction caused by high D-glucose is likely attenuated by insulin through the L-arginine/NO and O2•-/NADPH oxidase pathways. These findings are of interest for better understanding vascular dysfunction in states of foetal insulin resistance and hyperglycaemia.

Indexed as

15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidAcetophenonesArginineBiopterinsCalcitonin Gene-Related PeptideCationic Amino Acid Transporter 1Cyclic N-OxidesGene Expression RegulationGlucoseHumansHuman Umbilical Vein Endothelial CellsInsulinMitogen-Activated Protein Kinase 1Nitric OxideNitric Oxide Synthase Type IIIPrimary Cell Culture15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidAcetophenonesacetovanilloneArginineBiopterinsCalcitonin Gene-Related PeptideCationic Amino Acid Transporter 1Cyclic N-OxidesGlucoseInsulinMitogen-Activated Protein Kinase 1Nitric OxideNitric Oxide Synthase Type IIINOS3 protein, humanProto-Oncogene Proteins c-aktReactive Oxygen SpeciessapropterinSLC7A1 protein, humanSpin LabelstempolTranscription FactorsVasoconstrictor AgentsWDR77 protein, human

Identifiers

PMID25875935
PMCPMC4397070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.